[Federal Register Volume 83, Number 43 (Monday, March 5, 2018)]
[Notices]
[Pages 9320-9321]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04330]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-0571; Docket No. CDC-2018-0017]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled ``Minimum Data Elements (MDEs) 
for the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP).''

DATES: CDC must receive written comments on or before May 4, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0017 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Minimum Data Elements (MDEs) for the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP)--(OMB Control Number 0920-
0571, exp. 12/31/2018)--Revision--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC)

Background and Brief Description

    CDC seeks to request a three-year OMB approval to revise the 
information collection project approved under OMB Control number 0920-
0571. Based on feedback from grantees and internal subject matter 
experts, CDC proposes use of revised minimum data elements (MDEs), 
which decrease the estimated annualized time burden.
    Both breast and cervical cancers are prevalent among U.S. women. In 
2014, more than 236,000 women were diagnosed with breast cancer, and 
more than 12,000 women were diagnosed with cervical cancer. Evidence 
shows that deaths from both breast and cervical cancers can be avoided 
by increasing women screening services (mammography and Pap tests). 
However, women who are under- or uninsured, have no regular source of 
healthcare, and/or have recently immigrated to the U.S. typically 
underutilize screening services.
    Congress passed the Breast and Cervical Cancer Mortality Prevention 
Act of 1990, which directed CDC to establish the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP). The purpose of

[[Page 9321]]

the NBCCEDP is to increase breast and cervical cancer screening rates 
among priority populations by funding grantees to provide breast and 
cervical cancer screening services to eligible women. The NBCCEDP funds 
70 grantees including state health departments and the District of 
Columbia, universities, and tribes or tribal organizations.
    Priority populations for the NBCCEDP include women residing within 
defined geographical locations (as determined by the funded program) 
who are (1) at or below 250% of the federal poverty level, (2) aged 40-
64 years for breast cancer services, and aged 21-64 years for cervical 
cancer services, and (3) under- or uninsured.
    CDC issued a new funding opportunity announcement to support a 5-
year cooperative agreement under CDC-RFA-DP17-1701. The number of 
grantees will increase from 67 grantees to 70 grantees. The current 
program includes a stronger focus on grantees partnering with health 
systems to increase breast and cervical cancer screening rates.
    CDC proposes a revision to the MDEs to include removal of several 
data variables that are no longer relevant for CDC analyses, as well as 
collapsing/revising several data variables to reduce burden and 
increase clarity for respondents. The MDEs focus on the following 
areas: (1) Patient demographics; (2) breast cancer screening; (3) 
cervical cancer screening; (4) breast and cervical cancer diagnoses; 
(5) breast and cervical cancer treatment; (6) timeliness of services; 
and (7) patient navigation.
    Redesigned data elements will enable CDC to better gauge progress 
in meeting clinical service delivery processes and patient-level 
outcomes. Findings will allow CDC to assess program progress in meeting 
goals and monitor implementation activities, evaluate outcomes, and 
identify grantee technical assistance needs. In addition, data 
collected will inform program improvement and help identify successful 
activities that need to be maintained, replicated, or expanded.
    The total estimated annualized burden hours will decrease from 536 
to 350 hours. There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees..............  MDEs............              70               2            2.50             350
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             350
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-04330 Filed 3-2-18; 8:45 am]
 BILLING CODE 4163-18-P